PBRM1 and nonpapillary renal cell carcinoma: PBRM1 mutations tend to anti-correlate with BAP1 mutations in ccRCC, and that PBRM1- and BAP1-mutated tumors exhibit a different biology and are associated with markedly different outcomes.